Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Adv Drug Deliv Rev. 2019 Feb 12;148:344–359. doi: 10.1016/j.addr.2019.01.011

Fig. 5.

Fig. 5.

Graphical representation of nanocarrier-based drug optimization assay process in zebrafish. Five phases: 1) Nanocarrier-compound formulation 2) Assay development, 3) Assay optimization, 4) Nanocarrier-enabled enhancer screen, 5) Validation.